hospitalized COVID-19 patient
[용어속성] Term
Mendelian randomization study of obesity and type 2 diabetes in hospitalized COVID-19 patients
Short communication
Published on
Journal: Metabolism: clinical and experimental [Category] COVID19(2023년), SARS, 유전자 메커니즘,
Journal: Metabolism: clinical and experimental [Category] COVID19(2023년), SARS, 유전자 메커니즘,
[키워드] Analysis
applied
association
class
correlation
COVID-19
COVID-19 hospitalization
Critically ill
genetic marker
Genome
GWAS
Hospitalization
hospitalized COVID-19
hospitalized COVID-19 patient
hospitalized COVID-19 patients
independent
initiative
instrumental variable
mendelian randomization
obesity
objective
Patient
platform
reported
Research design
Result
risk
risk factor
shown
T2D
type 2 diabete
type 2 diabetes
was performed
[DOI] 10.1016/j.metabol.2022.155156 [Article Type] Short communication
[DOI] 10.1016/j.metabol.2022.155156 [Article Type] Short communication
Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections
SARS-CoV-2 감염 검출을 위한 민감하고 특이적인 혈청학적 ELISA
Article
[키워드] 113 patient
113 patients
95% CI
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
antibody
antibody levels
Antibody titer
Antibody titers
approved
Asymptomatic
collected
coronavirus
coronavirus disease
Coronavirus disease 2019
Coronavirus disease 2019 (COVID-19)
COVID-19
cytomegalovirus
develop
early phase
ELISA
enzyme
enzyme-linked immunosorbent
enzyme-linked immunosorbent assay
Enzyme-linked immunosorbent assay (ELISA)
epidemiological data
Epstein Barr virus
Escherichia coli
Hepatitis
herpes simplex
herpes simplex virus
hospitalized COVID-19 patient
hospitalized COVID-19 patients
human serum
identify
IgG antibodies
IgG immune response
immune response
immunodeficiency
Infection
Mild
N-protein
nucleocapsid protein
Nucleocapsid protein (N-protein)
number of infected
pandemic
Pathogens
Patient
PCR
positive PCR test
produced
Protein
provided
purified
remained
RT-PCR
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 infections
SARS-CoV-2 nucleocapsid
SARS-CoV-2 specific antibodies
SARS-CoV-2 spike
sensitive
sensitivity
sera
serological
serological assays
serological test
serum sample
serum samples
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
severe symptom
severe symptoms
specific IgG antibody
specificity
symptom onset
symptomatic infections
tested
the SARS-CoV-2
triggered
Vaccine
virus
[DOI] 10.1186/s12985-022-01768-4 PMC 바로가기 [Article Type] Article
[DOI] 10.1186/s12985-022-01768-4 PMC 바로가기 [Article Type] Article
Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab
중화 단일클론항체 밤라니비맙 치료 후 코로나19로 입원한 환자의 비인두 면봉 유전자 발현 패턴과 혈청 바이오마커 간의 관계
Randomized Controlled Trial
Published on
Journal: Journal of Translational Medicine [Category] SARS, 바이오마커, 유전자 메커니즘, 임상, 진단, 치료기술,
Journal: Journal of Translational Medicine [Category] SARS, 바이오마커, 유전자 메커니즘, 임상, 진단, 치료기술,
[키워드] absence
Analysis
Analytes
antibody formation
Antibody Response
approach
bamlanivimab
Biomarker
biomarker signature
Biomarkers
Blood
change
changes in
circulation
clinical
clinical trial
Cohort
collected
connection
coronavirus
coronavirus 2
coronavirus disease
Coronavirus disease 2019
correlated
COVID-19
CXCL10
CXCL11
detect
disease
Elecsys
Gene Expression
gene expression pattern
groups
healthy control
healthy controls
Hospitalized
hospitalized COVID-19 patient
hospitalized COVID-19 patients
IFNγ
IgA
IgG titer
IgG titers
IgM
IL-6
immune response
immunoassay
immunological
implementation
Infection
Inflammatory
inflammatory protein
Inflammatory response
interferon response
Level
Luminex
MCP-3
MONITOR
monoclonal antibody
nasopharyngeal
Nasopharyngeal swab
nasopharyngeal swab sample
Nasopharyngeal swab samples
nasopharyngeal swabs
Neutralizing
not affect
not significantly different
observation
observations
Patient
patient population
patients
patients hospitalized
patients with COVID-19
peaked
Peripheral blood
Placebo
presence or absence
profile
Protein
Randomized
receive
reductions
reductions in
relationship
remained
repeated measure
respiratory
RNA sequencing
RNA-Seq
SARS-CoV-2
SARS-COV-2 infection
Seroconversion
serology
serum
serum biomarker
Serum protein
serum proteins
serum sample
serum samples
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
similarities
single dose
systemic disease
therapeutic
Treatment
Treatment strategies
utility
viral-induced
was performed
was used
were used
while
with COVID-19
[DOI] 10.1186/s12967-022-03345-3 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1186/s12967-022-03345-3 PMC 바로가기 [Article Type] Randomized Controlled Trial
Definition of the Immune Parameters Related to COVID-19 Severity
COVID-19 심각도와 관련된 면역 매개변수의 정의
Article
[키워드] 95% CI
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Administered
Admission
allocation
among others
Analysis
analyzed
Blood
blood cell
blood cell count
caused
Cell
changes in
clinical decision
Clinical management
Cohort
coronavirus
COVID-19
COVID-19 outcome
COVID-19 patients
Critical
Cutoff
defined
Definition
described
disease
disease severity
fluctuations
for inclusion
granulocyte
groups
highlight
Hospitalization
hospitalized COVID-19 patient
hospitalized COVID-19 patients
immunological
immunological changes
intensive care
intensive care unit admission
Laboratory
Laboratory test
lymphocyte
Medical resources
Mild
moderate
non-survivor
offer
outcome
oxygen
oxygen support
Oxygen therapy
parameter
Patient
Peripheral blood
peripheral blood cell
peripheral blood cells
predict
Predictive
proof
recorded
ROC Curve
sensitivity
separated
severe acute respiratory syndrome Coronavirus
severity
Severity of disease
Severity Score
specificity
survival
survivor
symptomatic
the disease
therapy
Triage
[DOI] 10.3389/fimmu.2022.850846 PMC 바로가기 [Article Type] Article
[DOI] 10.3389/fimmu.2022.850846 PMC 바로가기 [Article Type] Article
Plasma Markers of Neutrophil Extracellular Trap Are Linked to Survival but Not to Pulmonary Embolism in COVID-19-Related ARDS Patients
호중구 세포외 트랩의 혈장 표지자는 COVID-19 관련 ARDS 환자의 생존과 관련이 있지만 폐색전증과는 관련이 없습니다
Article
[키워드] acute respiratory distress
acute respiratory distress syndrome
Admission
Analysis
ARDS
Biomarker
circulating
Clinical outcome
clinical outcomes
collected
Comparisons
complexes
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 progression
develop
Embolism
evaluate
Extracellular
hospital
hospitalized COVID-19 patient
hospitalized COVID-19 patients
Hypothesis
immunothrombosis
life-threatening
lung damage
Mann-Whitney test
marker
microthrombus
moderate disease
myeloperoxidase
NET
NETosis
NETs
neutrophil
Neutrophil extracellular trap
Neutrophil extracellular traps
non-survivor
Non-survivors
Occurrence
Patient
patients
patients hospitalized
plasma
Plasma levels
Prevent
pulmonary
Pulmonary embolism
recent
respiratory distress
Respiratory distress syndrome
responsible
restriction
severe COVID-19 patients
severe disease
severe patients
survival
survivor
syndrome
therapeutic target
total DNA
TRAP
were assessed
with COVID-19
worsening
[DOI] 10.3389/fimmu.2022.851497 PMC 바로가기 [Article Type] Article
[DOI] 10.3389/fimmu.2022.851497 PMC 바로가기 [Article Type] Article
Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection
입원한 COVID-19 환자 및 SARS-CoV-2 감염의 급성 후유증이 있는 환자의 신경병증 발생에 대한 혈장 바이오마커
Article
Published on
Journal: Neurology® neuroimmunology & neuroinflammation [Category] COVID19(2023년), MERS, SARS, 바이오마커, 치료기술, 치료법,
Journal: Neurology® neuroimmunology & neuroinflammation [Category] COVID19(2023년), MERS, SARS, 바이오마커, 치료기술, 치료법,
[키워드] Acidic
Activation
addition
Antigen
antigenemia
antigenic
antigenic stimulation
Anxiety
assessments
association
biochemical evidence
Blood
calculated
CNS
cognitive
concentrations
coronavirus
correlated
COVID-19
COVID-19 disease
detectable
detection
develop
diagnosis of COVID-19
dysfunction
Encephalopathy
enrolled
Evidence
evidence of
exhibited
groups
healthy control
Hospitalization
Hospitalized
hospitalized COVID-19 patient
hospitalized COVID-19 patients
hospitalized patient
Infection
initial
Injury
latent infection
life
light chain
manifestation
Measures
Mild
neurologic
neuronal
Neuropathogenesis
Neuropsychiatric
nucleocapsid antigen
occur
Older
PASC
pathogenic mechanism
pathogenic mechanisms
Patient
patients
patients hospitalized
plasma
plasma biomarker
PNP
presenting
Protein
recruited
required
respiratory
Respiratory Coronavirus
SARS-CoV-2
SARS-CoV-2 N
Simoa
Study participants
subjects
Symptom
Symptoms
symptoms onset
These data
were measured
with COVID-19
[DOI] 10.1212/NXI.0000000000001151 PMC 바로가기 [Article Type] Article
[DOI] 10.1212/NXI.0000000000001151 PMC 바로가기 [Article Type] Article
Clinical characteristics and risk factors for mortality among COVID-19 hospitalized patients in UAE: Does ethnic origin have an impact
Research Article
[키워드] 30-day mortality rate
addressed
Admission
admitted to ICU
age
Analysis
Anemia
association
average
C-reactive protein
Characteristics
chronic
Chronic kidney disease
chronic obstructive
clinical
Clinical characteristics
conducted
COPD
cough
COVID-19
COVID-19 case
COVID-19 infection
creatinine
Data analysis
deficiency
demographic characteristics
determine
disease manifestation
disease symptom
epidemiological
Evidence
ferritin
Fever
globe
help
hemoglobin
hospital
Hospital stay
Hospitalization
hospitalized COVID-19 patient
hospitalized patient
indicated
Infection
intensity
Kidney disease
knowledge
middle
Middle East
Mild
Mortality
mortality rate
mortality risk
multiple logistic regression
outcome
oxygen saturation
Patient
patients with COVID-19
preexisting comorbidity
pulmonary disease
recruited
reduce
reducing mortality
reported
reported symptom
respiratory rate
Result
retrospective
risk factor
Risk factors
risk of death
severity
single center
Symptom
Treatment
Univariate analysis
[DOI] 10.1371/journal.pone.0264547 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0264547 PMC 바로가기 [Article Type] Research Article
Splenic infarct in a COVID-19 patient under anticoagulant therapy with normal D-dimer levels
Case report
[키워드] abdominal pain
Acute myocardial infarction
Anticoagulant
anticoagulant therapy
Anticoagulant treatment
chest pain
Coagulopathy
Computerized tomography
COVID-19
COVID-19 patient
D-dimer level
described
discharged
drug dose
ECG
Follow-up
Hospitalization
hospitalized COVID-19 patient
laboratory parameter
Leukocytosis
LMWH
multisystemic
Myocardial
nine
Patient
patients
PCR positivity
Pneumonia
presenting
Prevent
problem
prophylactic dose
Prophylaxis
receiving
Seven
shown
Splenic
Splenic infarction
Thromboembolism
thrombosis
Thrombotic events
Treatment
was increased
was performed
[DOI] 10.1016/j.ijscr.2022.106847 [Article Type] Case report
[DOI] 10.1016/j.ijscr.2022.106847 [Article Type] Case report